| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer
|
Skolnik, Jeffrey M.
|
|
2005
|
57 |
4 |
p. 458-464
|
article
|
| 2 |
Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells
|
Lin, Yi-Hsien
|
|
2005
|
57 |
4 |
p. 525-532
|
article
|
| 3 |
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
|
Jermann, Monika
|
|
2005
|
57 |
4 |
p. 533-539
|
article
|
| 4 |
Apoptosis induced by glycoprotein (150-kDa) isolated from Solanum nigrum L. is not related to intracellular reactive oxygen species (ROS) in HCT-116 cells
|
Lee, Sei-Jung
|
|
2005
|
57 |
4 |
p. 507-516
|
article
|
| 5 |
A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy
|
Latz, Jane E
|
|
2005
|
57 |
4 |
p. 412-426
|
article
|
| 6 |
Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells
|
Serova, Maria
|
|
2005
|
57 |
4 |
p. 491-499
|
article
|
| 7 |
Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy
|
Latz, Jane E.
|
|
2005
|
57 |
4 |
p. 427-435
|
article
|
| 8 |
Development and validation of limited sampling models for topotecan lactone pharmacokinetic studies in children
|
Turner, P. Kellie
|
|
2005
|
57 |
4 |
p. 475-482
|
article
|
| 9 |
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells
|
Angela, Michelutti
|
|
2005
|
57 |
4 |
p. 517-524
|
article
|
| 10 |
Interpreting cell cycle effects of drugs: the case of melphalan
|
Lupi, Monica
|
|
2005
|
57 |
4 |
p. 443-457
|
article
|
| 11 |
Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer
|
Chedid, Silwan
|
|
2005
|
57 |
4 |
p. 540-544
|
article
|
| 12 |
Pharmacokinetics and phototoxicity of purpurin-18 in human colon carcinoma cells using liposomes as delivery vehicles
|
Sharma, Sulbha
|
|
2005
|
57 |
4 |
p. 500-506
|
article
|
| 13 |
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers
|
Ramanathan, Ramesh K.
|
|
2005
|
57 |
4 |
p. 465-474
|
article
|
| 14 |
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma
|
Kim, Seok Jin
|
|
2005
|
57 |
4 |
p. 436-442
|
article
|
| 15 |
Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients
|
Latz, Jane E
|
|
2005
|
57 |
4 |
p. 401-411
|
article
|
| 16 |
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro
|
Carr, Jocelyn L
|
|
2005
|
57 |
4 |
p. 483-490
|
article
|
Journal description